Servier

About Servier

Servier is a global pharmaceutical company founded in 1954, dedicated to the research, development, and distribution of innovative medicines. With a strong commitment to improving patient health, Servier operates in over 140 countries, providing a wide range of therapeutic solutions.

The company focuses on several key therapeutic areas, including cardiovascular diseases, diabetes, oncology, and neuropsychiatry. Servier’s mission is to offer high-quality medications that meet the needs of patients and healthcare professionals alike.

With a robust pipeline of new drugs and a dedication to research and development, Servier invests heavily in innovation. The company collaborates with various academic institutions and research organisations to advance medical science and bring new treatments to market.

Servier is also committed to sustainability and corporate social responsibility, actively engaging in initiatives that promote health education and access to medicines in underserved communities.

• Global Presence: Servier has a significant international footprint, with operations in Europe, Asia, Africa, and the Americas.
• Research and Development: The company allocates a substantial portion of its revenue to R&D, ensuring a continuous flow of innovative therapies.
• Patient-Centric Approach: Servier prioritises the needs of patients, striving to enhance their quality of life through effective treatment options.

In summary, Servier stands as a pillar in the pharmaceutical industry, driven by a passion for healthcare and a vision for a healthier future for all.